Table 1.
Baseline patients' data. Continuous variables are presented as median (25th- 75th percentiles) and categorical variables as number (percent). BMI: body mass index; BSA: body surface area; COPD: chronic obstructive pulmonary disease; LV: left ventricle; LVEDD; left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; PASP: pulmonary artery systolic pressure.
| Variable | Total number of patients (22) |
|---|---|
| Age (Years) | 73 (67–78) |
| Female | 16 (72.73%) |
| BMI (Kg/m2) | 29.45 (25.22–33.73) |
| BSA (m2) | 1.7 (1.6–1.9) |
| Diabetes mellitus | 11 (50%) |
| Hypertension | 15 (68.18%) |
| COPD | 3 (13.64%) |
| Heart Failure in the previous 2 weeks | 6 (28.57%) |
| Chronic kidney disease | 2 (9.09%) |
| Atrial fibrillation | 11 (50%) |
| Mitral valve bioprosthesis model | |
| Mosaic | 6 (27.27%) |
| Hancock | 1 (4.55%) |
| Perimount | 9 (40.9%) |
| Epic | 3 (13.64%) |
| Carpentier- Edward (Magna) | 1 (4.55%) |
| LVEDD (mm) | 45 (41–53) |
| LVESD (mm) | 30 (27–36) |
| PASP (mmHg) | 60 (55–75) |
| Indexed LV mass (g/m2) | 96.4 (80.6–121.3) |
| Ejection fraction (%) | 55 (50–60) |